TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24444116

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (4 grams over 15 minutes, followed by 16 grams over 24 hours)
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Matched placebo (4 grams over 15 minutes, followed by matched placebo over 24 hours)
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 1700
Study: 21919555

Group type: EXPERIMENTAL
Intervention: Aspirin (ASA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel (CLP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19423614

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg daily for 7-10 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo capsule daily for 7-10 days
Number of subjects: 23
Study: 17637587

Group type: EXPERIMENTAL
Intervention: Oral lorazepam 0.035 mg/kg (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral lorazepam 0.035 mg/kg (Group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral lorazepam 0.035 mg/kg (Group D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 60
Study: 16085789

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5 mg-10 mg/day; mean: 5.2 mg/day)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Risperidone (0.5 mg-2 mg/day; mean: 1.0 mg/day)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 12376586

Group type: EXPERIMENTAL
Intervention: Bupropion SR 300 mg/d for 26 weeks, increased to 400 mg/d if <5% weight loss at week 12
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study: 10503817

Group type: EXPERIMENTAL
Intervention: OAC (omeprazole-amoxycillin-clarithromycin)
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: OMC (omeprazole-metronidazole-clarithromycin)
Number of subjects: 805

Group type: COMPARATOR
Intervention: AC (amoxycillin-clarithromycin)
Number of subjects: 805

Group type: COMPARATOR
Intervention: MC (metronidazole-clarithromycin)
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: OAC and OMC
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 805
Study: 7850924

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU) administered via intravenous infusion or oral administration
Number of subjects: 0
Study: 2262487

Group type: EXPERIMENTAL
Intervention: Prophylactic CNS therapy (St. Jude regimen)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Prophylactic CNS therapy (other regimens)
Number of subjects: 94

Group type: COMPARATOR
Intervention: No prophylactic CNS therapy
Number of subjects: 94
Study: 7376944

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0
Study: 31821221

Group type: EXPERIMENTAL
Intervention: NEW Tx (Nutrition Exercise and Wellness Treatment)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 38
Study: 27915580

Group type: EXPERIMENTAL
Intervention: Wide Dynamic Range Compression (WDRC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: WDRC with Frequency Compression (FC)
Number of subjects: 16
Study: 25631299

Group type: EXPERIMENTAL
Intervention: Aura-i
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intubating laryngeal mask airway
Number of subjects: 30

Group type: COMPARATOR
Intervention: i-gel
Number of subjects: 30
Study: 23757125

Group type: EXPERIMENTAL
Intervention: Antimicrobial scrub type A
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Antimicrobial scrub type B
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard scrubs
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Antimicrobial scrubs
Number of subjects: 105
Study: 21768628

Group type: EXPERIMENTAL
Intervention: Circumpatellar electrocautery
Number of subjects: 262
Study: 19365010

Group type: EXPERIMENTAL
Intervention: 5 mg of tadalafil
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: 50 mg of sildenafil
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 17039333

Group type: EXPERIMENTAL
Intervention: Sodium citrate (0.52 mmol/kg/day in four doses)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 38
Study: 14507122

Group type: EXPERIMENTAL
Intervention: Massage with music therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Massage only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Music therapy only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 11104557

Group type: EXPERIMENTAL
Intervention: Metaproterenol (MP) at concentrations of 10(‐8)M to 10(‐6)M
Number of subjects: 27

Group type: COMPARATOR
Intervention: Baseline (no MP)
Number of subjects: 27
Study: 9095113

Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inferior vena cava filters (VCF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study: 8458056

Group type: EXPERIMENTAL
Intervention: Aztreonam regimen (2 gm every 8 hours) plus clindamycin (600 to 900 mg q8h) or nafcillin (1.5 gm to 2 gm every 6 hours)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control regimen (aminoglycoside) including amikacin (5 mg/kg q8h) plus cefazolin (1 gm q8h) or amikacin (500 mg every 12 hours) plus mezlocillin (4 gm q6h) or tobramycin plus ticarcillin (3 gm to 4 gm q4h)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Aztreonam regimen
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 84
Study: 2429619

Group type: EXPERIMENTAL
Intervention: Regimen PMP (CDDP 60 mg/m2, d 1, MMC 6 mg/m2, d 3, d 10 and PEP 5 mg/m2, d 3-7)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Regimen PM (CDDP 60 mg/m2, d 1 and MMC 6 mg/m2, d 3, d 10)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Regimen PMF (CDDP 60 mg/m2, d 1, MMC 6 mg/m2, d 3, d 10 and FT 800 mg/body, d 3-21)
Number of subjects: 74
Study: 30243410

Group type: EXPERIMENTAL
Intervention: Alcohol and Suicide Intervention for Suicidal Teens (ASIST)
Number of subjects: 50
Study: 26642949

Group type: EXPERIMENTAL
Intervention: Group A: two intra‐articular sacroiliac injections of local anaesthetic/corticosteroid guided by ultrasound in 7 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group B: conventional bipolar radiofrequency 'palisade' targeting lateral branch nerves of S1, S2, and S3
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group C: modified bipolar radiofrequency 'palisade' (needle distance >1cm)
Number of subjects: 60
Study: 24724767

Group type: EXPERIMENTAL
Intervention: Prolonged-release protein substitute
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional protein substitute
Number of subjects: 60
Study: 22424641

Group type: EXPERIMENTAL
Intervention: Pegilated‐Interferon‐alfa‐2b and ribavirin for 52 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 73
Study: 20968017

Group type: EXPERIMENTAL
Intervention: Laser therapy via the LGN‐222 quartz installation
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 320
Study: 18081857

Group type: COMPARATOR
Intervention: PPC/DC/E (phosphatidylcholine + deoxycholate + ethanol) injected into the right posterior trochanteric areas three times at weeks 0, 3, and 6.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 0
Study: 16368850

Group type: EXPERIMENTAL
Intervention: N2O 66% in the gas mixture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Air
Number of subjects: 80
Study: 15622315

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 154
Study: 11309186

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Thermal‐Tactile Stimulation (TS)
Number of subjects: 100
Study: 9490261

Group type: EXPERIMENTAL
Intervention: Repty index
Number of subjects: 40

Group type: COMPARATOR
Intervention: Barthel Index
Number of subjects: 40
Study: 7943451

Group type: EXPERIMENTAL
Intervention: mCPP (0.1 mg/kg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo saline
Number of subjects: 38
Study: 3314794

Group type: EXPERIMENTAL
Intervention: Brachytherapy
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control (no brachytherapy)
Number of subjects: 117
Study: 31935166

Group type: EXPERIMENTAL
Intervention: Rural Response System (RRS) intervention
Number of subjects: 2000
Study: 29889239

Group type: EXPERIMENTAL
Intervention: Artesunate (2 mg/kg/day for 5 days)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Chloroquine (25 mg base/kg over 3 days)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Chloroquine-primaquine (0.5 mg/kg/day for 14 days)
Number of subjects: 644

Group type: COMPARATOR
Intervention: Recurrence by day 28
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Primaquine radical cure
Number of subjects: 644
Study: 26208409

Group type: EXPERIMENTAL
Intervention: Recreational Soccer Program (RSP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Obese Control Group
Number of subjects: 30
Study: 23764933

Group type: EXPERIMENTAL
Intervention: Membrane stripping
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control (no membrane stripping)
Number of subjects: 134
Study: 24378018

Group type: EXPERIMENTAL
Intervention: Combining community case management of malaria (CCMm) and seasonal malaria chemoprevention (SMC)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Use of malaria rapid diagnostic test (RDT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: RDT and drugs stock-out
Number of subjects: 61
Study: 20881066

Group type: EXPERIMENTAL
Intervention: Betahistine 48 mg/d
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Betahistine 96 mg/d
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Betahistine 144 mg/d
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Betahistine (all doses)
Number of subjects: 79
Study: 18179497

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention (4 systematic assessments by a geriatrician, geriatrics advanced practice nurse, physical therapist, dietitian, and social worker during the first 9 months)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention
Number of subjects: 100
Study: 17158408

Group type: EXPERIMENTAL
Intervention: Diet with n-6:n-3 ratio of approximately 3:1 (enriched in alpha-linolenic acid, EPA, and DHA)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control diet with n-6:n-3 ratio of 10:1
Number of subjects: 258
Study: 14519377

Group type: COMPARATOR
Intervention: Hypoxic gas mixture (PET(O2)=50 mmHg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hyperoxic gas mixture (PET(O2)=140 mmHg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 8
Study: 10745254

Group type: EXPERIMENTAL
Intervention: GM-CSF (D5 to D14)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: G-CSF (D5 to D14)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: GM-CSF plus G-CSF (D5-D14 and D10-D14 respectively)
Number of subjects: 43

Group type: COMPARATOR
Intervention: G-CSF alone
Number of subjects: 43

Group type: COMPARATOR
Intervention: GM-CSF alone
Number of subjects: 43
Study: 8694202

Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch solution 10% (n=15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Human albumin 20% (n=15)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pentoxifylline continuously (1.2 mg.kg-1.h-1) (n=15)
Number of subjects: 45
Study: 1286500

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.84 mg IV, range: 0.2 mg to 1 mg)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Flumazenil and Placebo
Number of subjects: 146
Study: 2938985

Group type: EXPERIMENTAL
Intervention: Ovidol (Aaciphar SA, Brussels, Belgium)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Marvelon (Organon, SA, Brussels, Belgium)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Trigynon (Schering SA, Brussels, Belgium)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Desogestrel-containing preparations
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-containing oral contraceptives
Number of subjects: 38
Study: 29191052

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endurance exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching/Range of Motion (SROM)
Number of subjects: 0
Study: 26787366

Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil through inhalation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24708422

Group type: EXPERIMENTAL
Intervention: Materialise Mucosa
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional implant placement
Number of subjects: 59
Study: 22402258

Group type: EXPERIMENTAL
Intervention: Computer-based contraceptive assessment module with tailored health materials
Number of subjects: 2231

Group type: EXPERIMENTAL
Intervention: Computer-based contraceptive assessment module with generic health materials
Number of subjects: 2231

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2231
Study: 20381001

Group type: EXPERIMENTAL
Intervention: Eccentric exercise intervention (EG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 28
Study: 18356752

Group type: EXPERIMENTAL
Intervention: +LCPUFA
Number of subjects: 60

Group type: COMPARATOR
Intervention: -LCPUFA (control)
Number of subjects: 60
Study: 16043738

Group type: EXPERIMENTAL
Intervention: Hispanic patients
Number of subjects: 1283

Group type: EXPERIMENTAL
Intervention: African American patients
Number of subjects: 1283

Group type: COMPARATOR
Intervention: Non-Hispanic white patients
Number of subjects: 1283
Study: 12580844

Group type: COMPARATOR
Intervention: Low-calorie diet
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Low-calorie diet plus laser acupuncture
Number of subjects: 74
Study: 10475411

Group type: EXPERIMENTAL
Intervention: Antegrade/retrograde tepid blood cardioplegia (group I, n = 47)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Antegrade/retrograde cold blood cardioplegia with topical cooling (group II, n = 40)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Antegrade crystalloid cardioplegia with topical cooling (group III, n = 41)
Number of subjects: 128
Study: 8622020

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (FAC: fluorouracil 600 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 600 mg/m2)
Number of subjects: 2795

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (FAC)
Number of subjects: 2795

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 2795
Study: 1952174

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60
Study: 7332915

Group type: EXPERIMENTAL
Intervention: guanabenz
Number of subjects: 248

Group type: COMPARATOR
Intervention: methyldopa
Number of subjects: 248
Study: 31034463

Group type: EXPERIMENTAL
Intervention: Partial range of motion exercise (PRE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Full range of motion exercise (FRE)
Number of subjects: 44
Study: 27743126

Group type: EXPERIMENTAL
Intervention: 0.02 mg/kg midazolam (Midazolam Group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (Control Group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Both groups (Midazolam and Control)
Number of subjects: 72
Study: 25452229

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 964

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 964
Study: 24294837

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Cognitive psychological education (CPE)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Severity of childhood trauma
Number of subjects: 255
Study: 22950650

Group type: EXPERIMENTAL
Intervention: Mother's Kangaroo Care (MKC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Alternate Female Kangaroo Care (AFKC)
Number of subjects: 18
Study: 19237920

Group type: EXPERIMENTAL
Intervention: Transfusion of packed red blood cells at thresholds of 8, 9, or 10 g/dL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transfusion of packed red blood cells
Number of subjects: 30
Study: 17501887

Group type: EXPERIMENTAL
Intervention: polyglecaprone 6211 subcuticular sutures
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: polyglecaprone 25 subcuticular sutures
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: staples
Number of subjects: 90
Study: 15024332

Group type: EXPERIMENTAL
Intervention: Etidronate 200 mg/day for 2 weeks, then 9-week intermission, followed by 2 weeks of etidronate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 11579355

Group type: EXPERIMENTAL
Intervention: Rheolytic thrombectomy with AngioJet device
Number of subjects: 349
Study: 10738013

Group type: EXPERIMENTAL
Intervention: MDI-S (metered-dose inhaler with spacer)
Number of subjects: 123

Group type: COMPARATOR
Intervention: NEB (nebulizer)
Number of subjects: 123
Study: 8986484

Group type: EXPERIMENTAL
Intervention: Bi-level positive airway pressure (BiPAP) for 30 min
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) for 30 min
Number of subjects: 75

Group type: COMPARATOR
Intervention: Routine chest physiotherapy (RCP) combined with oxygen administration via nasal cannula for 10 min
Number of subjects: 75
Study: 1535592

Group type: EXPERIMENTAL
Intervention: 0.5% plain lidocaine (n = 7)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine with 1/320.000 adrenaline (n = 8)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine with 1/800.000 adrenaline (n = 7)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with 1/800.000 adrenaline (n = 6)
Number of subjects: 28
Study: 6432119

Group type: EXPERIMENTAL
Intervention: Placebo (sodium restriction group)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Diuretic (25 mg chlorthalidone)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Beta blocker (200 mg metoprolol)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Combined agent (chlorthalidone + metoprolol)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (normal diet group)
Number of subjects: 94
Study: 30702985

Group type: EXPERIMENTAL
Intervention: RT‐IND
Number of subjects: 20

Group type: COMPARATOR
Intervention: RT‐FIX
Number of subjects: 20
Study: 29637714

Group type: EXPERIMENTAL
Intervention: C1 esterase inhibitor (C1INH) 50 U/kg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 27554088

Group type: EXPERIMENTAL
Intervention: Single dose of 200 mg intravenous ibuprofen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single dose of 400 mg intravenous ibuprofen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single dose of 800 mg intravenous ibuprofen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple doses of 400 mg intravenous ibuprofen (four times per day)
Number of subjects: 12
Study: 24888705

Group type: EXPERIMENTAL
Intervention: CAL + BOP
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: PD + BOP
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 163
Study: 22158114

Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen
Number of subjects: 23

Group type: COMPARATOR
Intervention: Breathing 21% oxygen (control condition)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of resting MSNA
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of systolic BP
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of diastolic BP
Number of subjects: 23
Study: 20089547

Group type: EXPERIMENTAL
Intervention: One-time counselling by a geriatrician
Number of subjects: 591

Group type: COMPARATOR
Intervention: Control group (no changes in drug therapy)
Number of subjects: 591
Study: 18652103

Group type: EXPERIMENTAL
Intervention: Ephedrine IV (10 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline IV (placebo)
Number of subjects: 50
Study: 16170406

Group type: EXPERIMENTAL
Intervention: Citol (Abdi Ibrahim Ilaç San. ve Tic A.S., Istanbul, Turkey)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cipramil (H. Lundbeck A/S, Copenhagen, Denmark)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Citol and Cipramil
Number of subjects: 26
Study: 12559645

Group type: EXPERIMENTAL
Intervention: Fascial interposition (FI) component of a vas occlusion procedure
Number of subjects: 552

Group type: COMPARATOR
Intervention: No fascial interposition (no-FI) group
Number of subjects: 552
Study: 10486792

Group type: EXPERIMENTAL
Intervention: Continuous CEE medication (0.625 mg daily) with cyclical supplementation of 5 mg/day of medrogestone acetate for 24 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 34
Study: 8942409

Group type: EXPERIMENTAL
Intervention: High-selenium group (n = 7) received selenate-fortified formulas (0.36 mumol Se/L for preterm, 0.22 mumol Se/L for full-term)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-selenium group (n = 10) received non-selenium-fortified formulas (0.12 mumol Se/L for preterm, 0.11 mumol Se/L for full-term)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High-selenium group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: All infants
Number of subjects: 17
Study: 2011986

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (12-week program, 3 times per week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (maintained normal activities)
Number of subjects: 32
Study: 31493626

Group type: EXPERIMENTAL
Intervention: r-hGH Cristalia
Number of subjects: 135

Group type: COMPARATOR
Intervention: Genotropin™
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: r-hGH Cristalia and Genotropin™
Number of subjects: 135